Roundhill Cannabis ETF (WEED) News
Follow Roundhill Cannabis ETF (WEED) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 9 public stories across 6 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
M
Canopy Growth Q2 2027 Earnings Call Begins
Canopy Growth's quarterly earnings call has begun.
EQUITY | Nov 06, 2026, 02:57 PM UTC
M
Canopy Growth Q2 Revenue Rises 22%, Slightly Misses Estimates
EQUITY | Nov 06, 2026, 12:15 PM UTC
L
Canopy Growth Appoints Sebastian Blöte as Country Manager for Germany
Canopy Growth Corporation (“Canopy Growth”, “our”, “we” or the “Company”) (TSX:WEED) (NASDAQ:CGC), a leading global company committed to bettering lives through cannabis, today announced the appointment of Sebastian Blöt
NEWS | Sep 28, 2026, 11:30 AM UTC
L
Canopy Growth Corporation (WEED) Adjourns 2026 AGM for Lack of Quorum; New Date Oct. 23
Canopy Growth adjourned its Sept. 25, 2026 AGM due to not achieving the 33 1/3% quorum. The meeting will reconvene Oct. 23, 2026 at 1:00 p.m. ET, with prior proxies remaining valid and the company continuing to solicit v
NEWS | Sep 25, 2026, 06:01 PM UTC
L
Canopy Growth Announces Adjournment of 2026 Annual General and Special Meeting Due to Lack of Quorum
Canopy Growth Corporation (“Canopy Growth”, “our”, “we” or the “Company”) (TSX: WEED) (Nasdaq: CGC), a leading global company committed to bettering lives through cannabis, today announced that, due to the requisite quor
NEWS | Sep 25, 2026, 06:00 PM UTC
L
Canopy Growth Announces Extension of Proxy Voting Deadline for 2026 Annual General and Special Meeting
Canopy Growth Corporation (“Canopy Growth”, “our”, “we” or the “Company”) (TSX: WEED) (Nasdaq: CGC), a leading global company committed to bettering lives through cannabis, today announced it has extended the proxy votin
NEWS | Sep 23, 2026, 11:30 AM UTC
M
Canopy Growth expands European medical cannabis supply into the U.K.
Canopy Growth reached an agreement to supply four Canadian-grown medical flower strains to a cannabis-based medicines maker that will commercialize them under Canopy’s Spectrum Therapeutics brand in the U.K.
EQUITY | Sep 22, 2026, 12:11 PM UTC
M
Canopy Growth to supply four Canadian-grown strains in UK
Canopy Growth says it will supply four Canadian-grown medical cannabis flower strains for distribution in the United Kingdom.
EQUITY | Sep 22, 2026, 11:30 AM UTC
L
Canopy Growth broadens Australia medical cannabis portfolio with new formats
Canopy Growth announced a broadening of its medical cannabis portfolio in Australia across Spectrum Therapeutics and related product formats and formulations.
EQUITY | Sep 08, 2026, 11:30 AM UTC